Rødevand Erik, Mikkelsen Knut, Nordvåg Bjørn-Yngvar, Haga Hans-Jacob, Førre Øystein, Johnsen Villy, Kvien Tore Kristian
Klinikk for ortopedi og revmatologi, Revmatologisk avdeling, St. Olavs Hospital, 7006 Trondheim.
Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1643-5.
Glucocorticoid steroids are widely used as antiinflammatory and immunosuppressive medications and are well known to induce osteoporosis.
Randomised clinical trials and Cochrane reports on the use of calcium, vitamin D, bisphosphonates and hormones were reviewed and the results summarised. Additionally, national and some international recommendations were reviewed in order to propose recommendations for prophylaxis and treatment. The literature was identified by Medline searches.
Calcium and vitamin D prevent bone loss in low-to-medium-dose glucocorticoid steroid therapy. Bisphosphonates maintain or modestly increase lumbar and hip bone mass. The fracture risk was not significantly reduced in the spine and the hip. The clinical randomised trials and Cochrane reports conclude that bisphosphonates as well as calcium and vitamin D taken together are effective and the drugs of choice in prevention and treatment.
糖皮质激素被广泛用作抗炎和免疫抑制药物,且众所周知会诱发骨质疏松症。
回顾了关于使用钙、维生素D、双膦酸盐和激素的随机临床试验及Cochrane报告,并总结了结果。此外,还回顾了国内及一些国际建议,以便提出预防和治疗建议。通过医学文献数据库检索来确定文献。
钙和维生素D可预防低至中等剂量糖皮质激素治疗中的骨质流失。双膦酸盐可维持或适度增加腰椎和髋部骨量。脊柱和髋部的骨折风险并未显著降低。临床随机试验和Cochrane报告得出结论,双膦酸盐以及钙和维生素D联合使用是有效的,且是预防和治疗的首选药物。